Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 17, 2023
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
Christopher Raymond Maintained (ABBV) at Buy with Increased Target to $157 on, Jan 17th, 2023
Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $155 to $157 on, Jan 17th, 2023.
Christopher has made no other calls on ABBV in the last 4 months.
There are 12 other peers that have a rating on ABBV. Out of the 12 peers that are also analyzing ABBV, 6 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $165 on, Wednesday, December 14th, 2022
- Navaan Ty of "Exane BNP Paribas" Initiated at Hold and Held Target at $169 on, Thursday, December 8th, 2022
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022
- Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
- Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022
These are the ratings of the 6 analyists that currently disagree with Christopher
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $180 on, Thursday, January 5th, 2023
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Decreased Target to $154 on, Tuesday, December 20th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $182 on, Tuesday, December 6th, 2022
- Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
- Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
- David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
